Participants will discuss successful and ongoing programs designed to holistically improve the drug development process by incorporating the perspectives, needs and experiences of patients into the drug development process. Panelists will include the leader of a comprehensive patient program in a large biopharma company, a parent/patient advocate, and a representative from a clinical site network, to share and discuss different ideas.